… in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med …
of p53 and RAS for adjuvant chemotherapy in non small- cell lung cancer. J Clin Oncol 2007;25:…

… More than a quarter million patients in the United States and more than 1 million patients
worldwide are diagnosed with lung cancer each year, of which the overwhelming majority is …

… This study demonstrates the effectiveness of surgery and adjuvant chemotherapy in yielding
… Key Words: Surgery–Adjuvant chemotherapy–Small-cell lung cancer–T1-3N0M0 disease. …

… Given that adjuvant chemotherapy does not improve survival of stage IB NSCLC patients
(12… after adjuvant chemotherapy could improve survival of this lung cancer subgroup. …

… adjuvant chemotherapy for NSCLC increased in patients age 70 years or older following
reporting of pivotal adjuvant chemotherapy … Adoption of adjuvant chemotherapy appears to be …

… of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer (…
) or surgery followed by adjuvant chemotherapy (UFT (oral anti-cancer drug, a combination of …

… of adjuvant chemotherapy and to evaluate its impact on overall survival in node-negative
patients who undergo lung and chest wall resection for non-small cell lung cancer (NSCLC). …

… for adjuvant chemotherapy since May 2004 (31% versus 63%). Although new evidence to
support adjuvant chemotherapy in lung cancer is … Lung cancer is the leading cause of cancer-…

… Recently, randomized controlled trials (RCTs) have revealed a significant survival benefit
from adjuvant chemotherapy [5], and adjuvant chemotherapy following surgery has been …

… yet reported of adjuvant chemotherapy in patients with resected non–small-cell lung cancer
(… who received adjuvant chemotherapy and those who did not. Although patients treated with …